Literature DB >> 15251986

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow.

Robert F Wynn1, Claire A Hart, Carla Corradi-Perini, Liam O'Neill, Caroline A Evans, J Ed Wraith, Leslie J Fairbairn, Ilaria Bellantuono.   

Abstract

Homing of bone marrow stromal cells (MSCs) to bone and bone marrow after transplantation, important for the correction of conditions such as metabolic storage disorders, can occur but with poor efficiency. Substantial improvements in engraftment will be required in order to derive a clinical benefit from MSC transplantation. Chemokines are the most important factors controlling cellular migration. Stromal-derived factor-1 (SDF-1) has been shown to be critical in promoting the migration of cells to the bone marrow, via its specific receptor CXCR4. The aim of our study was to investigate CXCR4 expression on MSCs and its role in mediating migration to bone marrow. We show that CXCR4, although present at the surface of a small subset of MSCs, is important for mediating specific migration of these cells to bone marrow.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251986     DOI: 10.1182/blood-2004-02-0526

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  245 in total

1.  Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.

Authors:  Wei Zhu; Gang Liang; Zhiping Huang; Stephen B Doty; Adele L Boskey
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases.

Authors:  Alan Tyndall
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

3.  Homing of Mesenchymal Stem Cells.

Authors:  Reinhard Henschler; Erika Deak; Erhard Seifried
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

4.  Engineered cell homing.

Authors:  Debanjan Sarkar; Joel A Spencer; Joseph A Phillips; Weian Zhao; Sebastian Schafer; Dawn P Spelke; Luke J Mortensen; Juan P Ruiz; Praveen Kumar Vemula; Rukmani Sridharan; Sriram Kumar; Rohit Karnik; Charles P Lin; Jeffrey M Karp
Journal:  Blood       Date:  2011-10-27       Impact factor: 22.113

5.  Recent concepts for the roles of progenitor/stem cell niche in heart repair.

Authors:  Yuliang Feng; Xi-Yong Yu; Yigang Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

6.  Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair.

Authors:  David Zisa; Arsalan Shabbir; Michalis Mastri; Tyler Taylor; Ilija Aleksic; Mary McDaniel; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

Review 7.  Mesenchymal stem cells: Mechanisms of immunomodulation and homing.

Authors:  Hiroshi Yagi; Alejandro Soto-Gutierrez; Biju Parekkadan; Yuko Kitagawa; Ronald G Tompkins; Naoya Kobayashi; Martin L Yarmush
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

Review 8.  Therapeutic window, a critical developmental stage for stem cell therapies.

Authors:  Shengwen Calvin Li; Yuan-Ping Han; Brent A Dethlefs; William G Loudon
Journal:  Curr Stem Cell Res Ther       Date:  2010-12       Impact factor: 3.828

9.  Co-culture with TM4 cells enhances the proliferation and migration of rat adipose-derived mesenchymal stem cells with high stemness.

Authors:  Yanxia Luo; Ali Mohsin; Chenze Xu; Qizheng Wang; Haifeng Hang; Yingping Zhuang; Ju Chu; Meijin Guo
Journal:  Cytotechnology       Date:  2018-07-21       Impact factor: 2.058

10.  Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues.

Authors:  Vitali Alexeev; Adele Donahue; Jouni Uitto; Olga Igoucheva
Journal:  Cytotherapy       Date:  2013-02       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.